Advancing cancer gene therapy: the emerging role of nanoparticle delivery systems

Area of Science:

• Oncology
• Nanotechnology
• Molecular Biology

Background:

• Gene therapy offers precise targeting of oncogenes for cancer treatment.
• Traditional gene therapy faces challenges like limited efficacy and rapid degradation of genetic material in vivo.
• Advances in genetic science and bioinformatics enable gene delivery for therapeutic interventions.

Purpose of the Study:

• To review nanoparticle-based gene delivery systems for cancer therapy.
• To highlight strategies for enhancing gene therapy efficacy and stability.
• To explore various nanoscale delivery platforms and genetic payloads.

Main Methods:

• Review of current literature on gene therapy and nanotechnology in cancer.
• Analysis of nanoparticle engineering for genetic material encapsulation and protection.
• Discussion of gene modulation strategies including RNA interference, gene editing, and CAR technologies.
• Examination of diverse nanoscale delivery systems (polymers, lipids, inorganic materials).

Main Results:

• Multifunctional nanoparticles enhance the stability and therapeutic effectiveness of genetic materials.
• Nanoparticles facilitate targeted delivery of various genetic payloads (plasmid DNA, mRNA, siRNA) to cancer cells.
• Nanoscale delivery platforms show promise in improving the efficacy of cancer therapies.

Conclusions:

• Nanoparticle-based gene delivery represents a significant advancement in overcoming limitations of traditional gene therapy.
• Engineered nanoparticles offer a viable strategy for stable and targeted delivery of genetic materials to cancer cells.
• This approach holds potential for enhancing the overall efficacy of cancer treatment modalities.